Armata Pharmaceuticals
ARMP
21 hedge funds and large institutions have $3.37M invested in Armata Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 0 closing their positions.
506% more capital invested
Capital invested by funds: $555K → $3.37M (+$2.81M)
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
17% more funds holding
Funds holding: 18 → 21 (+3)
2.97% more ownership
Funds ownership: 1.64% → 4.6% (+3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$2.19M |
| 2 |
BlackRock
New York
|
+$110K |
| 3 |
Renaissance Technologies
New York
|
+$62.9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.27K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$402 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
-$9.95K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.1K |
ARMP Hedge Fund Activity: Q2 2020 in Review
21 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q2 2020, worth a combined $3.37M — up 506% from $555K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ARMP positions and 0 closed out — a net gain of 3 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, adding an estimated $2.19M. The largest seller was Stifel Financial, cutting an estimated $9.95K.
- 21 institutional investors held Armata Pharmaceuticals (ARMP) as of Q2 2020, up from 18 in Q1 2020.
- Funds reported $3.37M of Armata Pharmaceuticals stock for Q2 2020, up 506% quarter-over-quarter.
- 3 funds opened new Armata Pharmaceuticals positions in Q2 2020 and 0 closed out, a net change of +3 holders.
- The largest Armata Pharmaceuticals buyer in Q2 2020 was Bank of America, an estimated $2.19M added.
- The largest Armata Pharmaceuticals seller in Q2 2020 was Stifel Financial, an estimated $9.95K sold.
Based on aggregated 13F filings for Q2 2020.